Can elevated homocysteine increase migraine susceptibility?

Research and clinical evidence consistently associate elevated serum homocysteine levels with migraine susceptibility, particularly the migraine with aura (MA) subtype. This association is supported by genetic studies of the MTHFR C677T polymorphism and clinical observations where migraine patients exhibit significantly higher homocysteine levels compared to controls (e.g., 11.05 μmol/L vs 6.36 μmol/L in specific cohorts).

Clinical and genetic evidence

Clinical data reinforces the link between hyperhomocysteinemia and migraine across various populations.

• Genetic Susceptibility: The MTHFR C677T "TT" genotype, which impairs folate metabolism and raises homocysteine, is linked to a 2.0 to 2.5 times increased risk of migraine with aura.
• Case-Control Findings: Studies consistently find higher homocysteine levels in migraineurs. In pediatric populations, children with migraines show elevated levels compared to healthy peers, suggesting a fundamental biological association early in life.

Vascular mechanisms

Homocysteine contributes to migraine pathophysiology by inducing endothelial dysfunction and impairing vascular homeostasis.

• Nitric Oxide Depletion: Homocysteine reduces nitric oxide (NO) bioavailability by downregulating eNOS expression and depleting its essential cofactor, tetrahydrobiopterin (BH4). This leads to eNOS "uncoupling," where the enzyme produces damaging superoxide instead of protective NO.
• Structural and Barrier Effects: Elevated homocysteine increases arterial stiffness and promotes blood-brain barrier (BBB) disruption by activating matrix metalloproteinases (MMPs), which can facilitate the neurovascular events of a migraine attack.

Neurotransmitter and excitability effects

Beyond vascular health, homocysteine acts directly on neuronal pathways to lower the threshold for migraine triggers.

• NMDAR Agonism: Homocysteine and its metabolite, homocysteic acid (HCA), act as agonists at N-methyl-D-aspartate (NMDA) receptors. This increases calcium influx and neuronal excitability.
• Cortical Spreading Depression (CSD): By stimulating NMDA receptors, homocysteine reduces the stimulus intensity required to trigger CSD—the physiological hallmark of migraine aura. This creates a state of "hyperexcitability" that makes the brain more susceptible to headache-inducing stimuli.

Bottom line

Elevated homocysteine is a well-supported contributor to migraine susceptibility. It functions through a dual mechanism: impairing vascular endothelial function and lowering the neuronal threshold for cortical spreading depression via glutamate receptor activation. This suggests that managing homocysteine levels may be a plausible strategy for reducing migraine frequency or severity in susceptible individuals.